Paul Tudor Jones's CATX Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 18,106 shares of Perspective Therapeutics, Inc. (CATX) worth $61,741, representing 0.00% of the portfolio. First purchased in 2024-Q4, this short-term holding has been held for 4 quarters.
Based on 13F filings, Paul Tudor Jones has maintained this position in CATX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 33,946 shares. Largest reduction occurred in Q1 2025, reducing 28,577 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Perspective Therapeutics (CATX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Perspective Therapeutics (CATX) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -15,840 | Reduce 46.66% | 18,106 | $3.41 |
| Q1 2026 | +33,946 | New Buy | 33,946 | $4.17 |
| Q1 2025 | -28,577 | Sold Out | 0 | $0.00 |
| Q4 2024 | +28,577 | New Buy | 28,577 | $3.19 |
Paul Tudor Jones's Perspective Therapeutics Investment FAQs
Paul Tudor Jones first purchased Perspective Therapeutics, Inc. (CATX) in Q4 2024, acquiring 28,577 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Perspective Therapeutics, Inc. (CATX) for 4 quarters since Q4 2024.
Paul Tudor Jones's largest addition to Perspective Therapeutics, Inc. (CATX) was in Q1 2026, adding 33,946 shares worth $141,555.
According to the latest 13F filing for Q2 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 18,106 shares of Perspective Therapeutics, Inc. (CATX), valued at approximately $61,741.
As of the Q2 2026 filing, Perspective Therapeutics, Inc. (CATX) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Perspective Therapeutics, Inc. (CATX) was 33,946 shares, as reported at the end of Q1 2026.